Jolly J, Blackburn J
Int J Mol Sci. 2025; 26(4).
PMID: 40003994
PMC: 11855589.
DOI: 10.3390/ijms26041528.
Oyende Y, Taus L, Fatatis A
Cancers (Basel). 2025; 17(2).
PMID: 39858071
PMC: 11763358.
DOI: 10.3390/cancers17020290.
Kachuri L, Guerra G, Nakase T, Wendt G, Hansen H, Molinaro A
Nat Commun. 2025; 16(1):658.
PMID: 39809742
PMC: 11732991.
DOI: 10.1038/s41467-025-55919-6.
Khawar M, Afzal A, Si Y, Sun H
J Nanobiotechnology. 2024; 22(1):380.
PMID: 38943167
PMC: 11212433.
DOI: 10.1186/s12951-024-02630-1.
Sheikhlary S, Lopez D, Moghimi S, Sun B
Biomolecules. 2024; 14(4).
PMID: 38672519
PMC: 11048403.
DOI: 10.3390/biom14040503.
Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survival.
Kachuri L, Guerra G, Wendt G, Hansen H, Molinaro A, Bracci P
medRxiv. 2023; .
PMID: 37905116
PMC: 10614986.
DOI: 10.1101/2023.10.15.23296448.
Effect of Microsatellite Status and Pan-Immune-Inflammation Score on Pathological Response in Patients with Clinical Stage III Stomach Cancer Treated with Perioperative Chemotherapy.
Gulmez A, Coskun H, Koseci T, Ata S, Bozkurt B, Cil T
Medicina (Kaunas). 2023; 59(9).
PMID: 37763744
PMC: 10537642.
DOI: 10.3390/medicina59091625.
Association between IL-10 gene polymorphisms (- 1082 A/G, -819 T/C, -592 A/C) and hepatocellular carcinoma: a meta-analysis and trial sequential analysis.
Mei T, Aung H, Tung W, Naing C
BMC Cancer. 2023; 23(1):842.
PMID: 37684564
PMC: 10492326.
DOI: 10.1186/s12885-023-11323-1.
[Side effects of immune checkpoint inhibitor therapy : What intensive care specialists need to know].
Buchtele N, Knaus H, Schellongowski P
Med Klin Intensivmed Notfmed. 2023; 119(2):85-96.
PMID: 37661230
PMC: 10901948.
DOI: 10.1007/s00063-023-01057-0.
Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases.
Yoo K, Park D, Choi J, Marianayagam N, Lim M, Meola A
Front Oncol. 2023; 13:1223599.
PMID: 37637032
PMC: 10456862.
DOI: 10.3389/fonc.2023.1223599.
Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies.
Saraiva S, Jacinto T, Goncalves A, Gaspar D, Silva L
Pharmaceuticals (Basel). 2023; 16(8).
PMID: 37630983
PMC: 10459237.
DOI: 10.3390/ph16081067.
T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment.
Zheng Z, Wieder T, Mauerer B, Schafer L, Kesselring R, Braumuller H
Int J Mol Sci. 2023; 24(14).
PMID: 37511431
PMC: 10380781.
DOI: 10.3390/ijms241411673.
Epigenetic regulation and therapeutic targets in the tumor microenvironment.
Xie Z, Zhou Z, Yang S, Zhang S, Shao B
Mol Biomed. 2023; 4(1):17.
PMID: 37273004
PMC: 10241773.
DOI: 10.1186/s43556-023-00126-2.
Warning Signs From the Crypt: Aberrant Protein Glycosylation Marks Opportunities for Early Colorectal Cancer Detection.
Chandrasekar D, Guerrier C, Alisson-Silva F, Dhar C, Caval T, Schwarz F
Clin Transl Gastroenterol. 2023; 14(7):e00592.
PMID: 37141103
PMC: 10371329.
DOI: 10.14309/ctg.0000000000000592.
The evolving landscape of PCSK9 inhibition in cancer.
Oza P, Kashfi K
Eur J Pharmacol. 2023; 949:175721.
PMID: 37059376
PMC: 10229316.
DOI: 10.1016/j.ejphar.2023.175721.
Linking Physical Activity to Breast Cancer via Inflammation, Part 2: The Effect of Inflammation on Breast Cancer Risk.
Lou M, Drummond A, Swain C, Milne R, English D, Brown K
Cancer Epidemiol Biomarkers Prev. 2023; 32(5):597-605.
PMID: 36867866
PMC: 10150245.
DOI: 10.1158/1055-9965.EPI-22-0929.
Spontaneous Complete Regression of Colon Cancer Liver Metastases in a Lung Transplant Patient: A Case Report.
Zwart K, Ruigrok D, de Graaf-Bos M, Goldschmeding R, Koopman M, Bol G
Case Rep Transplant. 2023; 2023:9643370.
PMID: 36685719
PMC: 9851788.
DOI: 10.1155/2023/9643370.
RNA methylation and cellular response to oxidative stress-promoting anticancer agents.
Ponzetti M, Rucci N, Falone S
Cell Cycle. 2023; 22(8):870-905.
PMID: 36648057
PMC: 10054233.
DOI: 10.1080/15384101.2023.2165632.
Regulation of Immune Cells by microRNAs and microRNA-Based Cancer Immunotherapy.
Veiga R, Zambalde E, Cox L, Jucoski T, Kohler A, Mingorance Carvalho T
Adv Exp Med Biol. 2022; 1385:75-108.
PMID: 36352211
DOI: 10.1007/978-3-031-08356-3_3.
Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients.
Gambichler T, Stang A, Mansour R, Scheel C, Nick C, Abu Rached N
Cancers (Basel). 2022; 14(18).
PMID: 36139570
PMC: 9496745.
DOI: 10.3390/cancers14184410.